1-1 of 1
Susanne Fredén
Close
Sort by
Journal Articles

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

Clinical Trials & Observations
Jeanette Lundin, Hans Hagberg, Roland Repp, Eva Cavallin-Ståhl, Susanne Fredén, Gunnar Juliusson, Eija Rosenblad, Geir Tjønnfjord, Tom Wiklund, Anders Österborg
Journal: Blood
Blood (2003) 101 (11): 4267–4272.
https://doi.org/10.1182/blood-2002-09-2802
Published: 2003